# Simpex Pharma Pvt. Ltd – FDA Inspection, Mar 1, 2018

Source: https://www.keypedia.com/records/fda_inspections/simpex-pharma-pvt-ltd/49726c86-9c4b-4bdf-bc49-746326d23e9f
Source feed: FDA_Inspections

> FDA inspection 1042607 of Simpex Pharma Pvt. Ltd, March 01, 2018. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR parts 111 and 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1042607
- Company Name: Simpex Pharma Pvt. Ltd
- Inspection Date: 2018-03-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jai-p-singh/3843c2c6-a3b1-43b3-96f6-c3f1a72dc85b)
- [Company Rep](https://www.keypedia.com/people/valerie-l-whipp/70c97f44-c351-499b-afd3-166b4330ae52)

Company: https://www.keypedia.com/companies/simpex-pharma-pvt-ltd/884116a0-b7d0-45b2-b48f-aa045266ef0b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c